CSI Market
Sign In | Register

Sonoma Pharmaceuticals Inc (SNOA) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SNOA Annual Cash Flow →
From Sonoma Pharmaceuticals Inc through Jun 30 2025, changes in Jun 30 2026's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
3 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-0.33
Depreciation & amortization0.03
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.08
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.06
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Non Cash Interest Expense-
Property Plant And Equipment Additions-
Loss Due To Change In Fair Value Of Common Stock-
Common Stock Issued In Connection With Stock Purchase Agreement-
Reclassification Of Derivative Liabilities To Paid In Capital-
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-
Change In Provision For Discounts Rebates Distributor Fees And Returns-
Noncash Or Part Noncash Acquisition Net Deferred Consideration Current-
Noncash Or Part Noncash Acquisition Net Deferred Consideration Noncurrent-
Noncash Or Part Noncash Acquisition Taxes Payable-
Noncash Or Part Noncash Acquisition Net Deferred Revenue Current-
Increase Decrease In Deferred Consideration Net Of Discount-
Increase Decrease In Withholding Tax Payable0.32
Increase Decrease In Operating Lease Liability0.55
Increase Decrease In Contract With Customer Liability-0.42
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable1.04
Increase (Decrease) in Other Accounts Payable0.22
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.36
Other Working Capital-0.02
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-2.10
Discontinued operations0.00
Net Cash flow from Operating Activities-0.65
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Increase Decrease In Deposits-
Payments To Acquire Other Productive Assets Amount-
Increase Decrease In Deposit-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Proceeds from Other Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net-0.08
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock3.54
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Deferred Finance Costs Ownshare Lending Arrangement Issuance Costs Adjustment-
Deferred Offering Costs-
Proceeds From Cash Settlement Liability-
Principal Payments Related To Capital Leases-
Proceeds From Common Stock Liability-
Proceeds From Exercise Of Stock Options And Warrants-
Benefit From Lease Assumed Less Principal Payments On Rou Assets-
Payment On Atm Agreement Offering-
Proceeds From Stock Options And Purchase Warrants Exercised-
Payments On Ppp Loan-
Payments Of Atm Agreement Costs-
Payments For Fractional Shares Related To Reversesplit-
Proceeds From Insurance Premiums Financed-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities3.45
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.65
Total Cash Flow2.94
4 historic quarters locked

Sign in to unlock the full Sonoma Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Sonoma Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001683168-26-006024

Figures are derived from filed reports and may be restated. Historical data is subject to revision.